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BACKGROUND: The value of transient elastography for the non-invasive diagnosis of
alcohol-related liver fibrosis is subject to debate. We did an individual patient data
(IPD) meta-analysis to determine specific diagnostic cutoff values for liver stiffness in
alcohol-related fibrosis, and to assess the effect of aminotransferase concentrations,
bilirubin concentrations, and presence of asymptomatic and non-severe alcoholic
hepatitis on liver stiffness.
METHODS: We searched for studies that included patients with alcohol-related liver
disease, liver biopsy, and transient elastography, and with a statistical method for
determining the diagnostic cutoffs for alcohol-induced liver fibrosis on the basis of
the FibroScan results, in PubMed between Jan 1, 2000, and Sept 30, 2017. Native
data bases were obtained from corresponding authors in an Excel form. Pooled
diagnostic cutoffs for the various fibrosis stages were determined in a two-stage,
random-effects meta-analysis. The effects of aspartate aminotransferase (AST)
concentrations, bilirubin concentrations, and histological features of asymptomatic
and non-severe alcoholic hepatitis on liver stiffness cutoff were assessed in one-stage,
random-effects meta-analysis.
FINDINGS: Of 188 studies assessed, ten studies comprising 1026 patients were
included in the meta-analysis, yielded liver stiffness cutoffs of 7·0 kPa (area under the
receiver operating characteristic curve 0·83 [SE 0·02; 95% CI 0·79-0·87]) for F≥1
fibrosis, 9·0 kPa (0·86 [0·02; 0·82-0·90]) for F≥2, 12·1 kPa (0·90 [0·02; 0·86-0·94]) for
F≥3, and 18·6 kPa (0·91 [0·04; 0·83-0·99]) for F=4. AST and bilirubin concentrations
had a significant effect on liver stiffness, with higher concentrations associated with
higher liver stiffness values (p<0·0001), and with significantly higher cutoff values for
diagnosis of all fibrosis stages but F≥1. The presence of histological features of
asymptomatic and non-severe alcoholic hepatitis was associated with increased liver
stiffness (p<0·0001). In a multivariate analysis, AST (p<0·0001) and bilirubin
(p=0·0002) concentrations, and prothrombin activity (p=0·01), were independently
associated with the presence of histological features of asymptomatic and non-severe
alcoholic hepatitis. Lastly, specific liver stiffness cutoffs were determined on the basis
of concentrations of AST and bilirubin. Liver stiffness cutoff values increased in
patients with increased AST concentrations, bilirubin concentrations, or both.
INTERPRETATION: This IPD meta-analysis highlights the link between liver stiffness
and the histological features of asymptomatic and non-severe alcoholic hepatitis,
reflected by AST and bilirubin concentrations. In alcohol-related liver disease,
FibroScan assessments of liver fibrosis should take into account AST and bilirubin
concentrations through the use of specifically adjusted liver stiffness cutoffs.
FUNDING: None.
URL de la
notice http://okina.univ-angers.fr/publications/ua18378 [19]
DOI 10.1016/S2468-1253(18)30124-9 [20]
Lien vers le
document
https://www.thelancet.com/journals/langas/article/PIIS2468-1253
[21](18)30124-9/fulltext
Titre abrégé Lancet Gastroenterol Hepatol
Identifiant
(ID) PubMed 29983372 [22]
Liens
[1] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31505
[2] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31506
[3] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31507
[4] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=5429
[5] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=5434
[6] http://okina.univ-angers.fr/jerome.boursier/publications
[7] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31508
[8] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=5014
[9] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31510
[10] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31511
[11] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31512
[12] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31513
[13] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=5437
[14] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31514
[15] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=5515
[16] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31515
[17] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=5186
[18] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=31516
[19] http://okina.univ-angers.fr/publications/ua18378
[20] http://dx.doi.org/10.1016/S2468-1253(18)30124-9
[21] https://www.thelancet.com/journals/langas/article/PIIS2468-1253
[22] http://www.ncbi.nlm.nih.gov/pubmed/29983372?dopt=Abstract
Publié sur Okina (http://okina.univ-angers.fr)
